Phio Pharmaceuticals Announces Dosing of First Patient in

Trial targeting treatment of metastatic melanoma and other solid tumors...

Related Keywords

Portland ,Oregon ,United States ,Bridge View ,Brendan Curti ,Robert Bitterman ,Caitlin Kontulis ,Michael Adams ,Robertw Franz ,Judith Ann Hartmann ,Andrew Weinberg ,Providence Cancer Institute Of Oregon ,Joseph Health ,Nasdaq ,Earlea Chiles Research Institute ,Clinical Research ,Providence Cancer Institute In Portland ,Laboratory Of Basic Immunology ,Phio Pharmaceuticals Corp ,Agonox Inc ,Phio Pharmaceuticals ,Providence Cancer Institute ,Adoptive Cell Therapy ,Principal Investigator Brendan Curti ,Endowed Chair ,Research Institute ,Judith Ann Hartmann Endowed Chair ,Basic Immunology ,Cancer Institute ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Nasdaq Phio ,Ohio ,Ntasyl ,Immunooncology ,Unai ,